<info type="SequenceVariant">A118G</info> allelic expression imbalance of <info type="OrganismTaxon">human</info> <info type="GeneOrGeneProduct">mu opioid receptor (OPRM1)</info> caused by <info type="SequenceVariant">variant A118G</info>.

As a primary target for <info type="ChemicalEntity">opioid drugs</info> and <info type="ChemicalEntity">peptides</info>, the <info type="GeneOrGeneProduct">mu opioid receptor (OPRM1)</info> plays a key role in <info type="DiseaseOrPhenotypicFeature">pain perception</info> and <info type="DiseaseOrPhenotypicFeature">addiction</info>. <info type="SequenceVariant">Genetic variants</info> of <info type="GeneOrGeneProduct">OPRM1</info> have been implicated in predisposition to <info type="DiseaseOrPhenotypicFeature">drug addiction</info>, in particular the <info type="SequenceVariant">single nucleotide polymorphism A118G</info>, leading to an <info type="SequenceVariant">N40D substitution</info>, with an allele frequency of <info type="ChemicalEntity">10-32%</info>, and uncertain functions. We have measured allele-specific <info type="GeneOrGeneProduct">mRNA</info> expression of <info type="GeneOrGeneProduct">OPRM1</info> in <info type="OrganismTaxon">human</info> autopsy brain tissues, using <info type="SequenceVariant">A118G</info> as a marker. In <info type="ChemicalEntity">8</info> <info type="OrganismTaxon">heterozygous samples</info> measured, the <info type="GeneOrGeneProduct">A118 mRNA</info> allele was <info type="ChemicalEntity">1.5-2.5-fold</info> more abundant than the <info type="GeneOrGeneProduct">G118 allele</info>. Transfection into <info type="OrganismTaxon">Chinese hamster ovary cells</info> of a <info type="GeneOrGeneProduct">cDNA</info> representing only the coding region of <info type="GeneOrGeneProduct">OPRM1</info>, carrying <info type="ChemicalEntity">adenosine</info>, <info type="ChemicalEntity">guanosine</info>, <info type="ChemicalEntity">cytidine</info>, and <info type="ChemicalEntity">thymidine</info> in position <info type="SequenceVariant">118</info>, resulted in <info type="ChemicalEntity">1.5-fold lower</info> <info type="GeneOrGeneProduct">mRNA</info> levels only for <info type="GeneOrGeneProduct">OPRM1-G118</info>, and more than <info type="ChemicalEntity">10-fold lower</info> <info type="GeneOrGeneProduct">OPRM1 protein</info> levels, measured by <info type="GeneOrGeneProduct">Western blotting</info> and <info type="GeneOrGeneProduct">receptor binding assay</info>. After transfection and inhibition of transcription with <info type="ChemicalEntity">actinomycin D</info>, analysis of <info type="GeneOrGeneProduct">mRNA turnover</info> failed to reveal differences in <info type="GeneOrGeneProduct">mRNA stability</info> between <info type="GeneOrGeneProduct">A118</info> and <info type="GeneOrGeneProduct">G118 alleles</info>, indicating a defect in <info type="GeneOrGeneProduct">transcription</info> or <info type="GeneOrGeneProduct">mRNA maturation</info>. These results indicate that <info type="GeneOrGeneProduct">OPRM1-G118</info> is a functional <info type="SequenceVariant">variant</info> with deleterious effects on both <info type="GeneOrGeneProduct">mRNA</info> and <info type="GeneOrGeneProduct">protein yield</info>. Clarifying the functional relevance of <info type="SequenceVariant">polymorphisms</info> associated with susceptibility to a complex disorder such as <info type="DiseaseOrPhenotypicFeature">drug addiction</info> provides a foundation for clinical association studies.